Serotonin and interleukin-6: the role of genetic polymorphisms in IFN-induced neuropsychiatric symptoms.
| dc.rights.license | open | en_US |
| hal.structure.identifier | University of Barcelona | |
| dc.contributor.author | UDINA, Marc | |
| hal.structure.identifier | University of Barcelona | |
| hal.structure.identifier | Nutrition et Neurobiologie intégrée [NutriNeuro] | |
| dc.contributor.author | MORENO-ESPANA, Jose | |
| hal.structure.identifier | University of Barcelona | |
| hal.structure.identifier | Hospital del Mar Medical Research Institute [Barcelona, Spain] [IMIM] | |
| dc.contributor.author | NAVINES, Ricard | |
| hal.structure.identifier | Universitat Autònoma de Barcelona = Autonomous University of Barcelona = Universidad Autónoma de Barcelona [UAB] | |
| dc.contributor.author | GIMENEZ, Dolors | |
| hal.structure.identifier | Hospital del Mar Medical Research Institute [Barcelona, Spain] [IMIM] | |
| dc.contributor.author | LANGOHR, Klaus | |
| hal.structure.identifier | Centro de Regulación Genómica [CRG] | |
| dc.contributor.author | GRATACOS, Monica | |
| hal.structure.identifier | Nutrition et Neurobiologie intégrée [NutriNeuro] | |
| dc.contributor.author | CAPURON, Lucile
IDREF: 167018736 | |
| hal.structure.identifier | Hospital del Mar Medical Research Institute [Barcelona, Spain] [IMIM] | |
| dc.contributor.author | DE LA TORRE, Rafael | |
| hal.structure.identifier | Universitat Autònoma de Barcelona = Autonomous University of Barcelona = Universidad Autónoma de Barcelona [UAB] | |
| dc.contributor.author | SOLA, Ricard | |
| hal.structure.identifier | University of Barcelona | |
| hal.structure.identifier | Hospital del Mar Medical Research Institute [Barcelona, Spain] [IMIM] | |
| dc.contributor.author | MARTIN-SANTOS, Rocio | |
| dc.date.accessioned | 2022-03-23T11:20:18Z | |
| dc.date.available | 2022-03-23T11:20:18Z | |
| dc.date.issued | 2013-09-01 | |
| dc.identifier.issn | 1873-3360 | en_US |
| dc.identifier.uri | https://oskar-bordeaux.fr/handle/20.500.12278/136519 | |
| dc.description.abstractEn | Cytokines and serotonin neurotransmission may play an important role on the development of psychopathological symptoms during interferon (IFN) treatment. The aim of the present study was to investigate the association between IFN-induced depression, anxiety and fatigue and functional genetic variants at the interleukin-6 gene (IL-6) and serotonin transporter gene (SERT). 385 consecutive Caucasian outpatients with chronic hepatitis C initiating treatment with IFN-alpha and ribavirin were included. All patients were interviewed at baseline using the Structured Clinical Interview for DSM-IV (SCID-I) and those with a current major depressive disorder or anxiety disorder before starting treatment were excluded. Depression and anxiety were assessed at baseline during the treatment (at 4, 12, 24 and 48 weeks) using the Hospital Anxiety and Depression Scale and fatigue was evaluated using a visual analogue scale. The 5-HTTLPR region of SERT gene and the functional polymorphism located at the promoter region of IL-6 gene (rs1800795) were genotyped. Genotypic distribution was in the Hardy-Weinberg equilibrium for SERT (p=0.41) and for IL-6 (p=0.72) polymorphisms. At baseline we found only a significant effect of IL-6 polymorphism on fatigue symptoms. During antiviral treatment we reported that subjects with CC genotype (IL-6) presented significantly lower changes from baseline in IFN-induced depression (p=0.005) and IFN-induced anxiety (p=0.004). We did not find statistically significant differences on depression (p=0.21) or anxiety (p=0.15) between SS/SL and LL genotypes of SERT. Genetic variations in the IL-6 gene increase the risk of IFN-induced depression and anxiety. The IL-6 polymorphism was associated with fatigue rates in patients with chronic hepatitis C before treatment. Our study confirms the role of inflammatory mechanisms in IFN-induced psychopathological symptoms. | |
| dc.language.iso | EN | en_US |
| dc.subject.en | Adult | |
| dc.subject.en | Anti-Anxiety Agents | |
| dc.subject.en | Antidepressive Agents | |
| dc.subject.en | Antiviral Agents | |
| dc.subject.en | Anxiety | |
| dc.subject.en | Cohort Studies | |
| dc.subject.en | Depression | |
| dc.subject.en | Drug Therapy | |
| dc.subject.en | Combination | |
| dc.subject.en | Fatigue | |
| dc.subject.en | Genetic Predisposition to Disease | |
| dc.subject.en | Hepatitis C | |
| dc.subject.en | Chronic | |
| dc.subject.en | Humans | |
| dc.subject.en | INDEL Mutation | |
| dc.subject.en | Interferon-alpha | |
| dc.subject.en | Interleukin-6 | |
| dc.subject.en | Middle Aged | |
| dc.subject.en | Point Mutation | |
| dc.subject.en | Polyethylene Glycols | |
| dc.subject.en | Promoter Regions | |
| dc.subject.en | Genetic | |
| dc.subject.en | Prospective Studies | |
| dc.subject.en | Recombinant Proteins | |
| dc.subject.en | Ribavirin | |
| dc.subject.en | Serotonin | |
| dc.subject.en | Serotonin Plasma Membrane Transport Proteins | |
| dc.subject.en | Whites | |
| dc.title.en | Serotonin and interleukin-6: the role of genetic polymorphisms in IFN-induced neuropsychiatric symptoms. | |
| dc.title.alternative | Psychoneuroendocrinology | en_US |
| dc.type | Article de revue | en_US |
| dc.identifier.doi | 10.1016/j.psyneuen.2013.03.007 | en_US |
| dc.subject.hal | Sciences du Vivant [q-bio]/Neurosciences [q-bio.NC] | en_US |
| dc.identifier.pubmed | 23571152 | en_US |
| bordeaux.journal | Psychoneuroendocrinology | en_US |
| bordeaux.page | 1803-13 | en_US |
| bordeaux.volume | 38 | en_US |
| bordeaux.hal.laboratories | NutriNeurO (Laboratoire de Nutrition et Neurobiologie Intégrée) - UMR 1286 | en_US |
| bordeaux.issue | 9 | en_US |
| bordeaux.institution | Université de Bordeaux | en_US |
| bordeaux.institution | INRAE | en_US |
| bordeaux.peerReviewed | oui | en_US |
| bordeaux.inpress | non | en_US |
| bordeaux.import.source | pubmed | |
| hal.export | false | |
| workflow.import.source | pubmed | |
| dc.rights.cc | Pas de Licence CC | en_US |
| bordeaux.COinS | ctx_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.jtitle=Psychoneuroendocrinology&rft.date=2013-09-01&rft.volume=38&rft.issue=9&rft.spage=1803-13&rft.epage=1803-13&rft.eissn=1873-3360&rft.issn=1873-3360&rft.au=UDINA,%20Marc&MORENO-ESPANA,%20Jose&NAVINES,%20Ricard&GIMENEZ,%20Dolors&LANGOHR,%20Klaus&rft.genre=article |
Fichier(s) constituant ce document
| Fichiers | Taille | Format | Vue |
|---|---|---|---|
|
Il n'y a pas de fichiers associés à ce document. |
|||